Early research (Phase 1)Looking for participantsNCT06090669
What this trial is testing
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Who this might be right for
Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
National Cancer Institute (NCI) 75